Categorized | Business, Health, People, Pottstown

Healthy Women Program Features Pottstown’s Barton

Posted on 05 March 2011. Tags: , ,

Dr. Thea Barton

POTTSTOWN PA – A program titled “Menorrhagia: Causes and Treatment Options,” presented by Dr. Thea Barton of Women’s Healthcare PC in Pottstown PA, will be held March 23 (2011; Wednesday) beginning at 6 p.m. in the Chesmont Building conference rooms of Pottstown Memorial Medical Center, 13 Armand Hammer Blvd. The free event is sponsored by PMMC’s Healthy Woman initiative and is open to the public.

Barton will discuss causes and treatment of excessive menstrual bleeding, which can affect women in all stages of the reproductive cycle and have crippling effects on day to day activities. A PMMC therapist from its Pottstown CarePlex will also demonstrate the use of Therabands for stretching and mini stress-reduction breaks. Advance registration is requested; for more information or to register, call 610-327-7662.

Photo from PMMC

Share

One Response to “Healthy Women Program Features Pottstown’s Barton”

Trackbacks/Pingbacks

  1. Sunday’s Headlines In The Post | The Sanatoga Post says:
    March 6, 2011 at 11:38 am

    [...] Healthy Woman Program Features Pottstown’s Barton The March 23 presentation will be held in conference rooms at the Chesmont Building, across the street from Pottstown Memorial Medical Center. [...]


From Our Sponsors

RSS Health News

  • Indonesia's nationwide healthcare plan stumbles at first hurdle May 19, 2013
    JAKARTA (Reuters) - When a sick Indonesian baby died after 10 hospitals in Jakarta turned her family away in February, critics blamed a pilot health insurance scheme that had overwhelmed the city's public hospitals. […]
  • Saudi Arabia has another case of new coronavirus: WHO May 18, 2013
    LONDON (Reuters) - Saudi Arabia has reported another case of infection in a concentrated outbreak of a new strain of a virus that emerged in the Middle East last year and spread into Europe, the World Health Organization (WHO) said on Saturday. […]
  • Lundbeck says drug shows improvement in depression symptoms May 18, 2013
    COPENHAGEN (Reuters) - Danish pharmaceutical group Lundbeck and Japanese partner Takeda said on Saturday that data from clinical phase III studies with the antidepressant vortioxetine had shown significant improvement in patients' symptoms. […]
  • Virus found in Iowa hog population, possibly beyond May 17, 2013
    WASHINGTON (Reuters) - A potentially fatal hog virus, porcine epidemic diarrhea, has been found in the United States for the first time, government and private industry officials said on Friday, posing a new threat for the country's struggling pork producers. […]
  • Fever reducers don't slow children's recovery: study May 17, 2013
    NEW YORK (Reuters Health) - A review of past research finds that fever-reducing drugs have no effect on the speed of children's recovery from an infection, contrary to the fears of some doctors and parents. […]
  • Death toll from new bird flu in China rises to 36: WHO May 17, 2013
    LONDON (Reuters) - Four more people in China have died from a new strain of bird flu, bringing the death toll from the H7N9 virus to 36 from 131 confirmed cases, the World Health Organization (WHO) said on Friday. […]
  • Surgeons-in-training dislike new work hours: survey May 17, 2013
    NEW YORK (Reuters Health) - Most surgeons-in-training dislike new rules that limit how many hours they can work, according to a new study that also found the majority said they skirt the restrictions. […]
  • Higher-stakes soccer matches tied to more injuries May 17, 2013
    NEW YORK (Reuters Health) - Soccer matches played at a high level of competition are more likely to result in injuries - and in more serious ones - compared to less important games, according to a new study. […]
  • Endometriosis more common in lean women: study May 17, 2013
    NEW YORK (Reuters Health) - Heavy women are less likely to be diagnosed with endometriosis than their slimmer peers, according to a new study. […]
  • Novo Nordisk says completes hemophilia drug trial May 17, 2013
    COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said on Friday it had completed the first phase III trial of a hemophilia drug, N9-GP. […]

The Posts On Health At Twitter